Ex Vivo Cytokine Expansion of Peripheral Blood Ph-Negative Cells in Chronic Myeloid Leukaemia

References

• Fialkow P. J., Jacobson R. J., Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. American Journal of Medicine 1977; 63: 125–130
   PubMed Web of Science ®Google Scholar
• De Klein A., Geurts Van Kessel A., Grosveld G., Bartram C. R., Hagemeijer A., Bootsma D., Spurr N. K., Heis-Terkamp N., Groffen J., Stephenson J. R. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1982; 300: 765–767
   PubMed Web of Science ®Google Scholar
• Groffen J., Stephenson J. R., Heisterkamp N., De Klein A., Bartram C. R., Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93–99
   PubMed Web of Science ®Google Scholar
• Thomas E. D., Clift R. A., Fefer A., Appelbaum F. R., Beatty P., Bensinger W. I., Buckner C D., Cheever M. A., Deeg H. J., Doney K., Flournoy N., Greenberg P., Hansen J. A., Martin P., Mc Guffin R., Ramberg R., Sanders J. E., Singer J., Stevart P., Storb R., Sullivan K., Weiden P L., Witherspoon R. Marrow transplantation for the treatment of chronic myelogenous leukemia. Annals of Internal Medecine 1986; 104: 155–162
   PubMed Web of Science ®Google Scholar
• Goldman J. M., Apperley J. F., Jones L., Marcus R., Goolden A. W.G., Batchelor R., Hale G, Waldman H, Reid C D., Hows J., Gordon-Smith E., Catovsky D., Gallon D. A.G. Bone marrow transplantation for patients with chronic myeloid leukemia. New England Journal of Medicine 1986; 314: 202–207
   PubMed Web of Science ®Google Scholar
• Mc Glave P. B., De Fabritiis P., Deisseroth A., Goldman J., Bar Nett M., Reiffers J., Simonsson B., Carella C., Aepli D. Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups. The Lancet 1994; 343: 1486–1488
   PubMed Web of Science ®Google Scholar
• Deisseroth A. B., Zu Z., Claxton D., Hanania E. G., Fu S., Ellerson D., Goldberg L., Thomas M., Janicek K., Anderson W. F., Hester J., Korbling M., Durett A., Moen R., Berenson R., Heimfeld S., Hamer J., Calvert L., Tibbits P., Talpaz M., Kantarjian H., Champlin R, Reading C. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068–3076
   PubMed Web of Science ®Google Scholar
• Reiffers J., Mahon E X., Boiron J. M., Faberes C, Cony-Makhoul P., Broustet A. Autografting in chronic myeloid leukemia: an overview. Leukemia 1996; 10: 385–388
   PubMed Web of Science ®Google Scholar
• Coulombel L., Kalousek D. K., Eaves C. J., Gupta C. M., Eaves A. C. Long-term marrow culture reveals chro-mosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive myelogenous leukemia. New England Journal of Medicine 1983; 308: 1493–1498
   PubMed Web of Science ®Google Scholar
• Turhan A. G., Humphries R. K., Eaves C. J., Barnett M. J., Phillips G. L., Kalousek D, Klingemann K. H.G., Lansdorp P. L., Reece D. E., Shepherd J. D., Eaves A. C. Detection of breakpoint cluster region-negative and non-clonal hematopoiesis in vitro and in vivo after transplantation of cells selected in cultures of chronic myeloid leukemia marrow. Blood 1990; 76: 2404–2410
   PubMed Web of Science ®Google Scholar
• Verfaillie C. M., Miller W. J., Boylan K., McGlave P. B. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 1992; 79: 1003–1010
   PubMed Web of Science ®Google Scholar
• Leemhuis T., Leibowitz D., Cox G., Silver R., Srour E. F., Tricot G., Hoffman R. Identification of BCR/ABL negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow. Blood 1993; 81: 801–807
   PubMed Web of Science ®Google Scholar
• Kirk J. A., Reems J. A., Roecklein B. A., Van Devanter D. R., Bryant E. M., Radich J., Edmands S., Lee A., Torok-Storb B. Benign marrow progenitors are enriched in CD34+/HLA-DR10 population but not in the CD34+/38lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization. Blood 1995; 86: 737–743
   PubMed Web of Science ®Google Scholar
• Emerson S. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. Blood 1996; 87: 3082–3088
   PubMed Web of Science ®Google Scholar
• Lange W., Henschler R., Mertelsmann R. Biological and clinical advances in stem cell expansion. Leukemia 1996; 10: 943–945
   PubMed Web of Science ®Google Scholar
• Beradi A. C., Wang A., Levine J. D., Lopez P., Scadden D. T. Functional isolation and characterization of human hematopoietic stem cells. Science 1995; 267: 104–108
   PubMed Web of Science ®Google Scholar
• Jazwiec B., Mahon F. X., Pigneux A., Pigeonnier V., Reiffers J. 5-Fluorouracil Resistant CD34 + Cell Population from peripheral blood of CML patients contains Bcr-Abl negative progenitors cells. Experimental Hematology 1995; 23: 1509–1514
   PubMed Web of Science ®Google Scholar
• Mahon F. X., Pigeonnier-Lagarde V., Chahine H., Barbot C., Jazwiec B., Ripoche R., Reiffers J. Ex vivo cytokine expansion of peripheral blood 5-fluorou-racil-treated-CD34 positive chronic myeloid leukaemia cells increases the selection of Ph negative cells. British Journal of Haematology 1997; 98: 467–473
   PubMed Web of Science ®Google Scholar
• Malinge M. C., Mahon F. X., Delfau M. H., Daheron L., Kitzis A., Guilhot E, Tanzer J., Grandchamp B. Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukemia under interferon therapy. British Journal of Haematology 1992; 82: 701–707
   PubMed Web of Science ®Google Scholar
• Carlo-Stella C., Mangoni L., Piovani G., Almici C., Garau D., Caramatti C., Rizzoli V. In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfa-mide and recombinant granulocyte-macrophage colony-stimulating factor. Bone Marrow Transplantation 1991; 8: 265–272
   PubMed Web of Science ®Google Scholar
• Rice A., Boiron J-M., Barbot C., Dupouy M., Dubosc-Marchenay N., Dumain P., Lacombe F., Reiffers J. Cytokine-mediated expansion of 5-FU-resistant peripheral blood stem cells. Experimental Hematology 1995; 23: 303–308
   PubMed Web of Science ®Google Scholar
• Shah A. J., Smogorzewska E. M., Hannun C, Crooks G. M. FLT3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro. Blood 1996; 87: 3563–3570
   PubMed Web of Science ®Google Scholar
• Rusten L S., Lyman S., Veiby O. P., Jacobsen S. E. The FLT3 ligand is a direct and potent stimulator of the growth of primitive and commited human CD34+ bone marrow progenitor cells in vitro. Blood 1996; 87: 1317–1325
   PubMed Web of Science ®Google Scholar
• Petzer A., Zandstra P. W., Piret J. M., Eaves C. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. Journal of Experimental Medicine 1996; 183: 2551–2555
   PubMed Web of Science ®Google Scholar
• Piacibello W., Sanavio R, Garetto Severino L. A, Bergandi D., Ferrario J, Fagioli F, Berger M, Aglietta M. Extensive amplification and self reniewal of human primitive hematopoietic stem cell from cord blood. Blood; 1997; 89: 2644–2653
   PubMed Web of Science ®Google Scholar
• Lewis I. D, Haylok D. N, Moore S., Hughes T. P. Peripheral blood is a source of BCR-ABL-negative pre-pro-genitors in early chronic phase chronic myeloid leukemia. Leukemia 1997; 11: 581–587
   PubMed Web of Science ®Google Scholar